Cynthia Metierre

University of Sydney — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index768citations19works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(8), Genomics and Chromatin Dynamics(7), RNA Research and Splicing(5), RNA modifications and cancer(3), CAR-T cell therapy research(3)

Publications19 total

An alternate receptor for adeno-associated viruses
Cell·2025· 8 citedOpen Access
Intrinsically Disordered Regions Define Unique Protein Interaction Networks in <scp>CHD</scp> Family Remodelers
The FASEB Journal·2025· 1 citedOpen Access
Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers
2024· 1 citedOpen Access
Table of Contents
Cytotherapy·2024Open Access
Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity
Cytotherapy·2024· 4 cited
The Fusion of CLEC12A and MIR223HG Arises from a trans-Splicing Event in Normal and Transformed Human Cells
International Journal of Molecular Sciences·2021· 11 citedOpen Access
Structure–function relationships explain CTCF zinc finger mutation phenotypes in cancer
Cellular and Molecular Life Sciences·2021· 27 citedOpen Access
CTCF zinc finger mutations produce cellular phenotypes explained by structure-function relationships
Research Square (Research Square)·2021Open Access
Somatic mutations in CTCF zinc fingers produce cellular phenotypes explained by structure-function relationships
2021· 4 citedOpen Access
Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients
Cancers·2020· 14 citedOpen Access
Widespread aberrant alternative splicing despite molecular remission in chronic myeloid leukemia patients
2020· 5 citedOpen Access
CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer
International Journal of Molecular Sciences·2018· 26 citedOpen Access
CTCF Expression Is Essential for Somatic Cell Viability and Protection against Cancer
Preprints.org·2018· 8 citedOpen Access
The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo
Journal of Hematology & Oncology·2017· 29 citedOpen Access
CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic
Oncogene·2017· 54 citedOpen Access
Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development
The Journal of Pathology·2015· 324 citedOpen Access
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
QUT ePrints (Queensland University of Technology)·2015· 28 citedOpen Access
Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
JNCI Journal of the National Cancer Institute·2013· 173 cited
The cancer‐testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells
International Journal of Cancer·2013· 51 citedOpen Access

Frequent Co-authors

Charles G. Bailey(18), John E.J. Rasko(17), Rajini Nagarajah(8), Ulf Schmitz(7), Mehdi Sharifi Tabar(6), Bijay Dhungel(6), Jeff Holst(5), Patrick O’Young(5), Crystal Semaan(5), Qian Wang(4), Justin Wong(4), Yue Feng(4), Dadi Gao(3), Ladan Fazli(3), Melanie Lehman(3), Martin Gleave(3), Colleen C. Nelson(3), William Ritchie(3), Wunna Kyaw(3), Tatyana Laletin(3)